Mmastodon HealthHealth first seen 4 h ago, last 10 min ago, peak #1
Clues Emerge on Why Pancreatic Cancer Drug Stops Working
Original: Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working https://www.nytimes.com/2026/09/30/science/p
Scientists are reporting new clues about why daraxonrasib, a breakthrough targeted drug for pancreatic cancer, eventually stops working in patients. The research points to mechanisms of resistance that develop over the course of treatment. The findings are drawing attention among clinicians and patient advocates because pancreatic cancer remains one of the deadliest cancers, and resistance to new therapies is a major obstacle to long-term survival.
Why now: Fresh research into drug resistance touches hopes for better pancreatic cancer treatment, a disease with very low survival rates
daraxonrasibpancreatic cancerRevolution MedicinesNew York Times
Rank over time, top of the chart is #1. 12 snapshots from 4 h ago to 10 min ago.
Evidence
- Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working https://www.nytimes.com/2026/09/30/science/pancreatic-cancer-drug-daraxonrasib-ben-sasse-resistance.html # Science # Health # Medicine · nyt_politics@robot.villas · 2
API: https://socialmediatrends-api.osmike.com/v1/trends/515240